Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-67P (RNA, U6 small nuclear 67, pseudogene) is a human pseudogene that shares sequence similarity with U6 small nuclear RNA, which is a core component of the spliceosome—a cellular machine responsible for pre-mRNA splicing in eukaryotes. Unlike the functional U6 snRNA, RNU6-67P is a non-coding derived sequence and does not participate in spliceosome assembly or function. Pseudogenes such as RNU6-67P are the result of retrotransposition or genomic duplication events and serve as markers for evolutionary and genomic studies, particularly for analyzing the dynamics of retrotransposons like LINEs. RNU6-67P is located on human chromosome 13 (chr13:83298071-83298167, hg38). No known protein products, interactions, or direct biological functions have been assigned; it is not considered a relevant target for drug discovery or clinical applications.
None applicable. Pseudogenes like RNU6-67P are not drug targets; mechanisms of action are not defined
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 67, pseudogene (RNU6-67P).